mm2 Asia posts 13.2% increase in 1Q earnings to $7.3 mil

mm2 Asia posts 13.2% increase in 1Q earnings to $7.3 mil

By: 
Samantha Chiew
14/08/18, 11:09 pm

SINGAPORE (Aug 14): mm2 Asia reported 1Q19 earnings increased by 13.2% to $7.25 million, compared to $6.40 million in 1Q18.

This came on the back of the group’s revenue almost doubling to $49.0 million from $24.6 million in the previous year.

This was mainly contributed by the group’s business assets from Lotus Fivestar Cinemas in Malaysia and a newly acquired subsidiary, Cathay Cineplexes in 3Q18. The increase in revenue was also contributed by the group’s core business and post-production business.

As cost of sales increased by 73.4% y-o-y to $16.1 million, gross profit for 1Q19 came in at $32.9 million, 114.4% higher than $15.4 million last year.

Administrative expenses significantly increased to $18.9 million from $5.64 million, while finance expenses also saw a significant jump to $3.22 million from $0.16 million a year ago.

As at June 30, the group’s cash and cash equivalents stood at $54.4 million.

Melvin Ang, executive chairman of mm2 says, “Beyond the Chinese market, which offers huge growth potential, the group is also seeking opportunities of regional film co-productions; In May 2018, mm2 formed a strategic slate partnership to co-finance 6 Southeast Asian films over the next 3 years.”

Chang Long Jong, CEO of mm2 adds, “The Group is also in the midst of preparing the subsidiary [Vividthree Production] for its proposed spin-off and listing on the SGX Catalist Board. Similar to the listing of UnUsUaL, the proposed spin-off and listing of Vividthree is about creating the best operating environment for and sharpening the focus of the management of Vividthree. Moreover, this exercise allows Vividthree to raise the funds required for its new growth trajectories in digital IP asset development without relying on the Group’s financing; creating real value for the shareholders.”

Shares in mm2 closed at 42 cents on Tuesday.

Trial of John Soh starts on Monday; here's the backstory

SINGAPORE (Mar 22): The long-awaited trial of John Soh, the alleged mastermind behind the manipulation of shares in Blumont, LionGold and Asiasons Capital (now Attilan Group) back in 2013, will start on Monday. Together with his alleged co-conspirator and girlfriend Quah Su-Ling, he will face evidence painstakingly assembled by investigators over the last five years, and testimony from some of his closest associates who were involved in the massive rise and sudden collapse of the three stocks which wiped out $8 billion from the Singapore market. On March 20, Goh Hin Calm appeared in a pa....
Read More >>

Hunting for the truth redux: Our coverage of the penny stock saga attracted threats and lawsuits

SINGAPORE (Mar 22): If there’s one story published by The Edge Singapore that I will never forget, it will probably be “Hunting for the truth” (Issue 641, Sept 1, 2014). The piece was intended to mark the first anniversary of the steep rise and sudden collapse of shares in Asiasons Capital, Blumont Group and LionGold Corp, an event that battered confidence in the local stock market and contributed to a subsequent slump in trading volumes. The central element of that story — that John Soh Chee Wen had been identified by the authorities as the ringleader of the whole affair — garner....
Read More >>

This local start-up is using soft robotics to help rehabilitate the hands

SINGAPORE (Mar 22): Roceso Technologies designs and manufactures robotic gloves that are used to help stroke or spinal cord injury patients regain function in their hands through neurological and muscle rehabilitation. Called EsoGlove, the patent-pending device assists patients in conducting various repetitive tasks. The patient wears the glove, made from fabric and embedded with actuators, and moves as directed by simulations on a screen. The speed and duration of these exercises and the pressure exerted by the robotic glove can be altered, depending on the severity of the patient’s c....
Read More >>